CoChat
Sign Up
Cited by 192

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics

Verheijen, Jan, Sleegers, Kristel·2018·Trends in Genetics
DOI 10.1016/j.tig.2018.02.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tig.2018.02.007

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. Cuyvers, 2016, Genetic variations underlying Alzheimer’s disease: evidence from genome-wide association studies and beyond, Lancet Neurol., 15, 857, 10.1016/S1474-4422(16)00127-7 · DOI
  2. Steinberg, 2015, Loss-of-function variants in ABCA7 confer risk of Alzheimer’s disease, Nat. Genet., 47, 445, 10.1038/ng.3246 · DOI · Paper page
  3. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease, Nat. Genet., 41, 1094, 10.1038/ng.439 · DOI · Paper page
  4. Seshadri, 2010, Genome-wide analysis of genetic loci associated with Alzheimer disease, J. Am. Med. Assoc., 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  5. Hollingworth, 2011, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease, Nat. Genet., 43, 429, 10.1038/ng.803 · DOI · Paper page
  6. Lee, 2011, Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals, Arch. Neurol., 68, 320, 10.1001/archneurol.2010.292 · DOI · Paper page
  7. Bertram, 2008, Genome-wide association analysis reveals putative Alzheimer’s disease susceptibility loci in addition to APOE, Am. J. Hum. Genet., 83, 623, 10.1016/j.ajhg.2008.10.008 · DOI · Paper page
  8. Wijsman, 2011, Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE, PLoS Genet., 7, 10.1371/journal.pgen.1001308 · DOI
  9. Lambert, 2013, Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease, Mol. Psychiatry, 18, 461, 10.1038/mp.2012.14 · DOI · Paper page
  10. Lambert, 2010, Implication of the immune system in Alzheimer’s disease: evidence from genome-wide pathway analysis, J. Alzheimers Dis., 20, 1107, 10.3233/JAD-2010-100018 · DOI · Paper page
  11. Hong, 2010, Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease, J. Hum. Genet., 55, 707, 10.1038/jhg.2010.92 · DOI
  12. Liu, 2012, Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome-wide association studies, J. Neurochem., 120, 190, 10.1111/j.1471-4159.2011.07547.x · DOI
  13. Ramanan, 2012, Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks, Brain. Imaging Behav., 6, 634, 10.1007/s11682-012-9196-x · DOI
  14. Perez-Palma, 2014, Overrepresentation of glutamate signaling in Alzheimer’s disease: network-based pathway enrichment using meta-analysis of genome-wide association studies, PLoS One, 9, 10.1371/journal.pone.0095413 · DOI
  15. Xiang, 2015, Integrating genome-wide association study and brain expression data highlights cell adhesion molecules and purine metabolism in Alzheimer’s disease, Mol. Neurobiol., 52, 514, 10.1007/s12035-014-8884-5 · DOI
  16. Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer’s disease, N. Engl. J. Med., 368, 107, 10.1056/NEJMoa1211103 · DOI · Paper page
  17. Pottier, 2012, High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease, Mol. Psychiatry, 17, 875, 10.1038/mp.2012.15 · DOI · Paper page
  18. Beecham, G. (2017) Whole-genome sequencing in familial late-onset Alzheimer’s disease identifies rare variation in AD candidate genes, Alzheimer’s Association International Conference | July 16-20, 2017, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. London, England
  19. Allen, 2012, Novel late-onset Alzheimer disease loci variants associate with brain gene expression, Neurology, 79, 221, 10.1212/WNL.0b013e3182605801 · DOI
  20. Martiskainen, 2015, Transcriptomics and mechanistic elucidation of Alzheimer’s disease risk genes in the brain and in vitro models, Neurobiol. Aging, 36, 10.1016/j.neurobiolaging.2014.09.003 · DOI · Paper page
  21. Zhao, 2015, ABCA7 in Alzheimer’s disease, Mol. Neurobiol., 51, 1008, 10.1007/s12035-014-8759-9 · DOI
  22. Scherzer, 2004, Loss of apolipoprotein E receptor LR11 in Alzheimer disease, Arch. Neurol., 61, 1200, 10.1001/archneur.61.8.1200 · DOI · Paper page
  23. Li, 2015, Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer’s disease, Sci. Rep., 5
  24. Humphries, 2015, Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci, Mol. Cell. Neurosci., 67, 37, 10.1016/j.mcn.2015.05.003 · DOI
  25. Wang, 2016, Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease, Genome Med., 8, 104, 10.1186/s13073-016-0355-3 · DOI · Paper page
  26. Ciryam, 2016, A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation, Proc. Natl. Acad. Sci. U. S. A., 113, 4753, 10.1073/pnas.1516604113 · DOI
  27. Darmanis, 2015, A survey of human brain transcriptome diversity at the single cell level, Proc. Natl. Acad. Sci. U. S. A., 112, 7285, 10.1073/pnas.1507125112 · DOI · Paper page
  28. Caglayan, 2012, Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain, Arch. Neurol., 69, 373, 10.1001/archneurol.2011.788 · DOI
  29. Verheijen, 2016, A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease, Acta Neuropathol., 132, 213, 10.1007/s00401-016-1566-9 · DOI · Paper page
  30. Chapuis, 2013, Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology, Mol. Psychiatry, 18, 1225, 10.1038/mp.2013.1 · DOI · Paper page
  31. Allen, 2015, Late-onset Alzheimer disease risk variants mark brain regulatory loci, Neurol. Genet., 1, e15, 10.1212/NXG.0000000000000012 · DOI · Paper page
  32. Parikh, 2014, Genetics of PICALM expression and Alzheimer’s disease, PLoS One, 9, 10.1371/journal.pone.0091242 · DOI
  33. Delay, 2016, miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease, Alzheimers Res. Ther., 8, 20, 10.1186/s13195-016-0186-x · DOI
  34. Vaquero-Garcia, 2016, A new view of transcriptome complexity and regulation through the lens of local splicing variations, eLife, 5, 10.7554/eLife.11752 · DOI · Paper page
  35. Xu, 2002, Genome-wide detection of tissue-specific alternative splicing in the human transcriptome, Nucleic Acids Res., 30, 3754, 10.1093/nar/gkf492 · DOI
  36. Mills, 2012, Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases, Neurobiol. Aging, 33, 10.1016/j.neurobiolaging.2011.10.030 · DOI
  37. Lai, 2014, Genome-wide profiling of alternative splicing in Alzheimer’s disease, Genom. Data, 2, 290, 10.1016/j.gdata.2014.09.002 · DOI
  38. Mills, 2013, RNA-Seq analysis of the parietal cortex in Alzheimer’s disease reveals alternatively spliced isoforms related to lipid metabolism, Neurosci. Lett., 536, 90, 10.1016/j.neulet.2012.12.042 · DOI
  39. Raj, T. (2017) Genetically Regulated Transcriptomic Study of Alzheimer’s Disease Yields Mechanistic Insights, Alzheimer’s Association International Conference, July 16-20, 2017, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. London, England
  40. Pottier, 2016, TYROBP genetic variants in early-onset Alzheimer’s disease, Neurobiol. Aging, 48, 10.1016/j.neurobiolaging.2016.07.028 · DOI · Paper page
  41. Ma, 2015, TYROBP in Alzheimer’s disease, Mol. Neurobiol., 51, 820, 10.1007/s12035-014-8811-9 · DOI · Paper page
  42. Christopher, 2017, Neuroepigenetic mechanisms in disease, Epigenetics Chromatin, 10, 47, 10.1186/s13072-017-0150-4 · DOI
  43. Lord, 2014, The epigenetic landscape of Alzheimer’s disease, Nat. Neurosci., 17, 1138, 10.1038/nn.3792 · DOI · Paper page
  44. Chibnik, 2015, Alzheimer’s loci: epigenetic associations and interaction with genetic factors, Ann. Clin. Transl. Neurol., 2, 636, 10.1002/acn3.201 · DOI · Paper page
  45. Yu, 2015, Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease, JAMA Neurol., 72, 15, 10.1001/jamaneurol.2014.3049 · DOI · Paper page
  46. Rawlik, 2016, Imputation of DNA methylation levels in the brain implicates a risk factor for Parkinson’s disease, Genetics, 204, 771, 10.1534/genetics.115.185967 · DOI
  47. Ernst, 2015, Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues, Nat. Biotechnol., 33, 364, 10.1038/nbt.3157 · DOI
  48. Harari, O. (2017) Cell-Type Profiling to Identify the Transcriptomic Downstream Events Triggered By Early-Onset Autosomal Dominant AD Mutations Alzheimer’s Association International Conference | July 16-20, 2017, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, London, England
  49. Matarin, 2015, A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology, Cell Rep., 10, 633, 10.1016/j.celrep.2014.12.041 · DOI · Paper page
  50. Ray, 2010, Analysis of Alzheimer’s disease severity across brain regions by topological analysis of gene co-expression networks, BMC Syst. Biol., 4, 136, 10.1186/1752-0509-4-136 · DOI
  51. Shendure, 2008, The beginning of the end for microarrays?, Nat. Methods, 5, 585, 10.1038/nmeth0708-585 · DOI
  52. Tyner, 2017, The UCSC Genome Browser database: 2017 update, Nucleic Acids Res., 45, D626
  53. Ciarlo, 2013, An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer’s disease brain samples, Dis. Model Mech., 6, 424
  54. Sutherland, 2011, Understanding the pathogenesis of Alzheimer’s disease: will RNA-Seq realize the promise of transcriptomics?, J. Neurochem., 116, 937, 10.1111/j.1471-4159.2010.07157.x · DOI
  55. Blencowe, 2006, Alternative splicing: new insights from global analyses, Cell, 126, 37, 10.1016/j.cell.2006.06.023 · DOI
  56. Malik, 2013, CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing, J. Neurosci., 33, 13320, 10.1523/JNEUROSCI.1224-13.2013 · DOI · Paper page
  57. Tan, 2013, Bridging integrator 1 (BIN1): form, function, and Alzheimer’s disease, Trends Mol. Med., 19, 594, 10.1016/j.molmed.2013.06.004 · DOI
  58. Killick, 2014, Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway, Mol. Psychiatry, 19, 88, 10.1038/mp.2012.163 · DOI · Paper page
  59. Zhou, 2014, Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer’s disease, PLoS One, 9
  60. Schnetz-Boutaud, 2012, Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene, Ann. Hum. Genet., 76, 448, 10.1111/j.1469-1809.2012.00727.x · DOI
  61. Satoh, 2014, A comprehensive profile of ChIP-Seq-based PU.1/Spi1 target genes in microglia, Gene Regul. Syst. Biol., 8, 127

Cited by

Sorted by citations

Metadata

Authors
Verheijen, J., & Sleegers, K.
Venue
Trends in Genetics
Publisher
Elsevier BV
Published
2018-06
Volume
34
Issue
6
Pages
434-447
ISSN
0168-9525
DOI
10.1016/j.tig.2018.02.007
Cited by
192
References
30
Language
en
Licence
Funders
  • European Commission Seventh Framework Programme for research, technological development and demonstration (305299)
  • Flanders Impulse Program on Networks for Dementia Research
  • Alzheimer Research Foundation (SAO-FRA)
  • University of Antwerp Research Fund

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review